Purchase Order W9114F25PA019
Award Date
5/1/25
Potential Completion Date
9/30/29
Potential Value
$165K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Biomerieux Deutschland GMBH
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency awarded a $331,303.46 firm fixed-price purchase order contract to Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization based in Germany. The contract is for the provision of Matrix Assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) equipment and supplies for VITEK MS Prime non-virtual clinical and MAESTRIA PC systems, to support U.S. military medical facilities in Germany. The contract is not set aside and was awarded on May 1, 2025...
The U.S. Defense Health Agency (DHA) awarded a firm-fixed-price purchase order contract to Biomerieux Deutschland GMBH, a foreign-owned for-profit organization, for the lease of a Matrix Assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) mass spectrometer and associated services. The one-year base period contract, valued at $412,360.03, has four one-year option periods and is to be performed at Landstuhl Regional Medical Center in Germany. The contract includes delivery,...
This federal contract award is for the lease of a MALDI-TOF mass spectrometer by the U.S. Army Medical Command (MEDCOM) to Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization based in Germany. The contract, valued at $409,211.06, was awarded on April 17, 2015 with a final completion date of May 19, 2020. The contract has no set-aside designation, indicating open competition. Biomerieux Deutschland GMBH is the prime contractor on this award and has an established relationship...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract is to provide Biomerieux reagents and supplies to be used with government-owned analyzers, as well as the lease of a Virtuo B-Unit module, for the period of October 1, 2022 to September 30, 2023. The potential value of the contract is $249,612.61. This procurement was a sole source award under FAR...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
This federal contract award, W9114F20P0003, was issued by the Defense Health Agency to Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization based in Germany. The contract, valued at $289,274.04, is for the provision of VITEK 2 ANALYZER & REAGENTS on a "COST PER REPORTABLE TEST" basis. The contract has a firm fixed price and runs through November 30, 2024. Biomerieux Deutschland GMBH is an established vendor for the U.S. military, having previously been awarded...
The U.S. Department of the Army Medical Command (MEDCOM) awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Deutschland GMBH, a German-based company, on September 30, 2024. The firm fixed-price call, valued at $6,224.48, is part of a larger $2 million BPA awarded on September 20, 2022, which is designed to supply laboratory items to support U.S. military medical facilities in Europe. The BPA call involves the delivery of reagents, medical supplies, and laboratory equipment, such as...
This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for "ORGANISM GN/GP IDENTIFICATION" services. The $245,279.50 contract runs from October 1, 2021, through September 30, 2026, and does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. Division, provides a range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the...
This federal contract award to Bioscientia Institut FÜR Medizinische Diagnostik GMBH, doing business as Bioscientia Medizin. Labor. Service., is for the provision of clinical reference laboratory testing services for the Landstuhl Regional Medical Center in Germany. The contract, valued at $205,427.56, was awarded by the Defense Health Agency on November 1, 2024, with a completion date of April 30, 2025. This award is a delivery order against an Indefinite Delivery Contract (IDC) held by...
The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract to Biomerieux Inc. for the supply of 0017 "SUSEPTIBILITY CARDS" with a ceiling value of $867,621.50. The period of performance runs from October 1, 2020 through September 30, 2023. This requirement was not set aside for any small business category. Biomerieux Inc., a global leader in in vitro diagnostics, is providing its specialized microbiological testing solutions to support infectious disease...